Published on in Vol 9, No 2 (2021): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23548, first published .
WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

Junjie Bi   1 * , MM ;   Wei Yang   1 * , MB ;   Ping Hao   2 * , MB ;   Yongmei Zhao   1 , MM ;   Dan Wei   1 , MB ;   Yipeng Sun   1 , PhD ;   Yuhua Lin   1 , MM ;   Meng Sun   3 , MM ;   Xuan Chen   3 , MD ;   Xuming Luo   1 , MB ;   Shanqun Li   4 , MD, PhD ;   Wei Zhang   3 * , MM ;   Xiongbiao Wang   1 * , MD, PhD

1 Department of Respiratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

2 Department of Nursing, Putuo Hospital, Shanghai University Of Traditional Chinese Medicine, Shanghai, China

3 Department of Respiratory Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

4 Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China

*these authors contributed equally

Corresponding Author:

  • Xiongbiao Wang, MD, PhD
  • Department of Respiratory Medicine
  • Putuo Hospital
  • Shanghai University of Traditional Chinese Medicine
  • No.164, LanXi Road
  • Shanghai, 200062
  • China
  • Phone: 86 13818666735
  • Email: xiongbiao6@yahoo.com